Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

H
Omari, Sundus

University of Mississippi
(T1530-01-04) Design of Experiment Multi-level Categoric Design Model for Formulation Parameters’ Optimization of Raloxifene Hydrochloride Solid Dispersion Produced by Hot-Melt Extrusion
Sundus Omari
Favorite
H.N. Barros, Caio

National Institute for Bioprocessing Research
(M1330-03-15) Effect of Atomic Layer Coatings on the Stability of Solid Myoglobin Formulations
Caio H.N. Barros
Favorite
Ha, Eun-Sol

Pusan National University
(T1030-03-18) Solubility Measurement and Modeling of Bisacodyl in Mono Solvent and Binary Solvent Mixture, and Its Application for Pharmaceutical Industry
Eun-Sol Ha
Favorite
(T1330-03-18) Equilibrium Solubility, Thermodynamic Modeling and Solubility Parameters of Itraconazole in Solvent Mixtures at Various Temperatures
Eun-Sol Ha
Favorite
Haeusler, Olaf

Roquette Pte., Ltd.
(T1130-03-20) Fast Tablet Hard Coating with Xylitol
Olaf Haeusler
Favorite
(T1530-09-58) Exploring Applications of Plant-Derived Polymers in Fused Deposition Modeling of Oral Pharmaceutical Tablets
Olaf Haeusler
Favorite
Haga, Yuya

Osaka University
(T1130-04-22) The Effect and Distribution of Amorphous Nanosilica Particle in the Brain and Microglial Cells
Yuya Haga
Favorite
(W1130-04-22) Valproic Acid Elevates HIF-1α-mediated CGB Expression and Suppresses Glucose Uptake in BeWo Cells
Yuya Haga
Favorite
Hageman, Michael

University of Kansas
(M1230-11-72) Encapsulation of Zidovudine via Spray-Drying for Taste-Masking for Incorporation into an Orally Dispersible Film
Michael Hageman
Favorite
(M1230-12-78) Disruption of Octreotide Interactions with the Bile Acid-Phospholipid Mixed Micelles Using Bile Acid Sequestrants
Michael Hageman
Favorite
(M1530-11-72) Enhanced Dissolution of Amphotericin B through Development of Amorphous Solid Dispersions Containing Polymer and Surfactants
Michael Hageman
Favorite
(T1130-01-06) Cyclodextrin Modulation of Lanreotide Gel Formation and Diffusional Release from an Emulated Subcutaneous Delivery Device
Michael Hageman
Favorite
(T1530-03-15) Enhancing Oral Absorption of a Poorly Water Soluble Anticancer Drug via Prodrug Modification
Michael Hageman
Favorite
Hagen, Natalie

National Institutes of Health
(T1430-06-40) Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Pharmacokinetics of PTH-IA in Mice
Natalie Hagen
Favorite
Haggag, Yusuf

University of Michigan
(T1230-03-15) Controlled Release of Monoclonal Antibodies from Long-Acting PLGA-Coated Implants
Yusuf Haggag
Favorite
Haidar, Sam

US Food and Drug Administration
(M1330-06-39) Regulatory Perspective of Considerations in Endogenous Therapeutic Analyte Bioanalysis
Sam Haidar
Favorite
Haider, Mohamed

University of Sharjah
(T1330-01-06) Statistical Optimization of Stable Quercetin Nanoparticles for Tumor Targeting
Mohamed Haider
Favorite
Haight, Brian

Leistritz Extrisiom
(M0930-08-51) Peak Shear and the Effect of Kneading Block Geometries on Twin Screw Granulation Process Design
Brian Haight
Favorite
(M1330-08-53) Better Together: Thermally Unstable Drug Granulated Using a Thermal Process?
Brian Haight
Favorite
Hai, Min

Ohio State University
(M1530-05-29) The Effect of Cancer-Associated Cachexia on the Pharmacokinetics of Extra-vascularly Administered Monoclonal Antibodies
Min Hai
Favorite
Haksar, Priyanka

Evonik India Pvt., Ltd.
(T1530-02-13) Scalability of EUDRATEC ^® Fasteric, an Advanced Technology to Target the Duodenum for Improved Absorption
Priyanka Haksar
Favorite
Halbert, Gavin

University of Strathclyde
(T1430-08-53) Getting Sticky with It – Formulation Tenacity in 3D Printing
Gavin Halbert
Favorite
(W0930-08-51) Linking 3DP Manufacturing with SIFT-MS Volatiles Organic Compound Analysis
Gavin Halbert
Favorite
Haley, Jeffrey

Celanese Corporation
(M1030-01-06) Release Tunability of Exemestane from EVA Implants
Jeffrey Haley
Favorite
Haley, Ryan

Accurant Biotech
(W1030-06-36) Novel Technical Breakthrough: qPCR with Reported LLOQ of 8 Copies / mg DNA in a 20 µL Reaction
Ryan Haley
Favorite
Hallak, Hussein

Teva Pharmaceutical Industries Ltd.
(T1230-10-63) TV-46000, a Novel Long Acting Injectable (LAI) Formulation of Risperidone, Forms a Stable and Robust Subcutaneous Depot, Even under Extreme Conditions: Prediction from Dog and Minipig to Human
Hussein Hallak
Favorite
Hall, Brendan

Q2 Solutions
(T1430-06-39) A Process of Method Development for Tissue Homogenization and Analysis to Eliminate Binding and Matrix Effects Using Surrogate Matrices
Brendan Hall
Favorite
Hall, Jeffrey

ImageProVision, Inc.
(M1230-09-59) Artificial Intelligence Based Particle Characterization for Predictive Insight of Drug Product Quality and Performance
Jeffrey Hall
Favorite
Hall, Jesse

University of Miami
(T1330-10-64) Advancing Neuro-Regenerative Therapies: Scalable Manufacturing and Purification of Extracellular Vesicles for Treating Neurodegenerative Diseases
Jesse Hall
Favorite
Halquist, Matthew

Virginia Commonwealth University
(T1330-11-74) Novel LAAM Immediate Release Capsule for Treating Opioid Use Disorder
Matthew Halquist
Favorite
Halstenberg, Laura

MilliporeSigma a Business of Merck KGaA
(T1030-01-05) Hydrophilic Polymers in Spray Dried Amorphous Dispersions - Exploring Polyvinyl Alcohol
Laura Halstenberg
Favorite
Haltaufderhyde, Kirk

EpiVax, Inc.
(T1530-10-64) Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Kirk Haltaufderhyde
Favorite
Hamdi, Mohamed

University of Sadat City
(M0930-03-51) Boosting Antitumor Immune Response against Breast Cancer Cells Using Doxorubicin and Zinc Oxide Nanoparticles Co-loaded Lipid Nanocarrier
Mohamed Hamdi
Favorite
(M1430-03-19) Antimicrobial and Angiogenic Silver Nanoparticles and Verapamil Double-Layered Electrospun/3D Printed Wound Healing Patch for Accelerated Wound Healing
Mohamed Hamdi
Favorite
(T1030-12-79) Extrusion of Customized PLLA Filaments Reinforced with Zinc Oxide Nanoparticles for Fabrication of 3D Anti-tumor Printlets
Mohamed Hamdi
Favorite
(W1030-03-16) Preparation of ZnO Nanoparticles/Doxorubicin Loaded PLLA Nanofiberous Patch for Tissue Restoration and Immunotherapy in Breast Cancer
Mohamed Hamdi
Favorite
Hamed, Rania

Al-Zaytoonah University of Jordan
(M0930-01-05) Loratadine Nanosuspension-Loaded In Situ Gel: A Promising Thermo-Responsive Delivery System for the Treatment of Allergic Rhinitis
Rania Hamed
Favorite
(W1130-01-06) Development and Characterization of Ciprofloxacin Nanoemulsion-Loaded Bigels of Different Oleogel to Hydrogel Ratios: A Comparative Study
Rania Hamed
Favorite
Hammad, Alaa

Al-Zaytoonah University of Jordan
(W1130-01-06) Development and Characterization of Ciprofloxacin Nanoemulsion-Loaded Bigels of Different Oleogel to Hydrogel Ratios: A Comparative Study
Alaa Hammad
Favorite
Hammarlund-Udenaes, Margareta

Uppsala University
(W0930-05-30) Comparison of Paclitaxel Distribution across CNS and PNS Barriers after Administration of Cremophor EL/Ethanol Solubilized, Albumin-Bound and Micellar Paclitaxel
Margareta Hammarlund-Udenaes
Favorite
Hampl, Vojtech

University of Chemistry and Technology Prague
(M1530-01-03) Drug Nanocrystals Enable Rapid Formulation Transfer from Liquid-Phase Pre-clinical Testing to First-in-Human Solid Dosage Forms
Vojtech Hampl
Favorite
Hamrén, Bengt

AstraZeneca
(T1030-10-65) A Review of Immunogenicity and Its Effect on Efficacy and Safety of Biologics as Reported on the Prescribing Label to Support Strategic Assessment and Planning Labeling Communications
Bengt Hamrén
Favorite
(W0930-10-66) Leveraging Nausea Exposure-Response Relationship to Optimize Titration and Dose Selection Decisions for Cotadutide
Bengt Hamrén
Favorite
Hanafy, Amira

University of Bonn
(T0930-04-25) ISMICAP: A Model for Delving into Blood-Brain Barrier Mysteries
Amira Hanafy
Favorite
Hanafy, Mahmoud

University of Texas at Austin
(T1330-03-15) Viable Eukaryotic Cell Dry Powders Prepared by Thin Film Freeze-Drying
Mahmoud Hanafy
Favorite
Han, Chao

Tavotek Biotherapeutics
(M1030-10-65) Clinical Correlation of Conventional Allometric Scaling Approach for PK Predictions of FcRn Enhanced and Protease Resistant Long-Acting mAbs, TAVO101 and TAVO103
Chao Han
Favorite
(T1530-10-63) Prediction of Human PK for Multispecific Antibody TAVO412 Using Non-linear Population PK Model and Allometric Scaling
Chao Han
Favorite
Han, Duanduan

Waters Corporation
(M1330-09-56) Lipid Nanoparticle Impurity Monitoring Using Single Quadrupole Mass Detection for Regulated Environments
Duanduan Han
Favorite
Hanes, Justin

Johns Hopkins University
(M1330-12-81) Development of Nanofiber-Based, Anti-proliferative Sutures for Glaucoma Surgery
Justin Hanes
Favorite
Haney, Staci

University of Nebraska Medical Center
(W1130-04-27) The Effect of MO-OH-Nap Tropolone on Osteosarcoma Cellular Metabolism
Staci Haney
Favorite
Han, Hye-Ri

Chungbuk National University
(T1130-12-79) Development of Calcium Silicate Film-Coated Tablet as a Coloring Agent
Hye-Ri Han
Favorite
Han, Hyojin

Korea University
(M1130-10-64) Effect of Amounts of DMSO and Incubation Time on BBB-PAMPA Permeability of Drugs with High and Low BBB Permeability
Hyojin Han
Favorite
(T1530-08-51) Effect of Morphologies and Process Parameters on Aerodynamic Performance of Fluticasone Propionate in Dry Powder Inhaler
Hyojin Han
Favorite
(W1230-02-12) Polymorphism and Solvatomorphism of Niclosamide-Camostat Cocrystals and Bioavailability Enhancement of Low-Solubility API via Co-Crystallization
Hyojin Han
Favorite
Han, Mark

United States Pharmacopeia
(M1230-09-56) Trace Level Quantification of Nitrosamine Impurities in Tuberculosis Medicines by LC-MS/MS
Mark Han
Favorite
Hannestad, Jonas

Tranquis Therapeutics
(T1530-03-21) A First-in-Human Assessment for TQS-168, Including Safety, Tolerability, Pharmacokinetics, Formulation Selection, and Food Effect in Healthy Volunteers
Jonas Hannestad
Favorite
Han, Qiang

US Food and Drug Administration
(M1430-08-54) Analysis of Manufacturing Deficiencies for Immediate Release Tablets in Abbreviated New Drug Applications
Qiang Han
Favorite
Hanrahan, Michael

Kansas Analytical Services, LLC
(M1230-09-62) Detecting Low-Level Crystallinity in ASD-Like Samples Using SSNMR Techniques
Michael Hanrahan
Favorite
Hara, Hideto

Takeda Pharmaceutical Company Limited
(W1030-12-77) Application of Machine Learning to the Development of Lipid Nanoparticle
Hideto Hara
Favorite
hargrove, Derek

University of Connecticut
(M1130-11-75) Radiation-Induced Tumor Penetration of Mesoporous Silica Nanoparticles for Enhanced Treatment of Ovarian Cancer Peritoneal Metastasis
Derek hargrove
Favorite
Harkins, Seth

Meso Scale Diagnostics
(M1230-06-37) Development of a Sensitive and Specific Phospho-Tau 217 [Tau (pT217)] Biomarker Assay for Alzheimer’s Disease in Plasma and Serum
Seth Harkins
Favorite
(T1230-06-37) Expansion of the Human Immuno-Oncology Assay Portfolio on a Multiplexed Electrochemiluminescence Platform
Seth Harkins
Favorite
(T1230-06-38) Performance of a Digoxigenin Antibody-Based Electrochemiluminescent Hybridization Assay: A HELISA Alternative for Low Femtomolar Detection of an Antisense Oligonucleotide
Seth Harkins
Favorite
Harms, Meike

Merck KGaA
(T1230-12-79) P188 – Polymeric Carrier for Solid Dispersion Enabling Formulations of PROTACs
Meike Harms
Favorite
Harris, David

Merck & Co., Inc.
(M1330-01-03) Formulation Testing of TiO2-Free Film Coating Alternatives from Three Film Coat Vendors
David Harris
Favorite
Harris, Samuel

Integral BioSystems
(T1030-01-02) Enhancement of Permeation of an Anti-Glaucoma Medication Brinzolamide via OcuSurf™ Lipid Nanoparticles
Samuel Harris
Favorite
Harrod, Hayley

Mercer University
(M0930-01-06) Formulation and Characterization of Ionic Liquid-Containing (IL) Melatonin Orally Dissolving Films (ODFs) for Buccal Drug Delivery
Hayley Harrod
Favorite
Harr, Thomas

University of Wisconsin Madison
(W1130-01-05) Fibronectin (FN) Binding Efficacy of PEGylated FUD (PEG-FUD) Peptide in Bleomycin Treated Animal Model for the Treatment of Pulmonary Fibrosis
Thomas Harr
Favorite
Hart, James

BASF SE Pharma Solutions
(M0930-05-32) Theoretical and Experimental Polymer-Polymer Miscibility Prediction: An Insight to In Vivo Compatibility
James Hart
Favorite
Hartle, Matthew

Aliri
(T0930-06-37) Highly Sensitive Analysis Using EVOSEP-LC/MS Assay for Targeted PD-L1 and PD1 Expression Level for Predicting Response to Immune Checkpoint Inhibitors
Matthew Hartle
Favorite
Hartman, Victoria

Precision NanoSystems, Inc.
(T1030-03-17) Optimized and Scalable LNP Composition for RNA Vaccine Delivery
Victoria Hartman
Favorite
Hartmeier, Paul

Duquesne University
(M1030-11-72) Guided Assembly of Lymph Node Stromal Cells Using a Biomaterial Formulation
Paul Hartmeier
Favorite
(T1430-01-04) Analysis and Simulation of In Vivo Nanoparticle Protein Carrier Pharmacokinetics
Paul Hartmeier
Favorite
Harvie, Pierrot

Precision NanoSystems, Inc.
(M1230-03-17) Strategies for Producing Clinical and Commercial RNA-LNP Drug Products
Pierrot Harvie
Favorite
(T1030-03-17) Optimized and Scalable LNP Composition for RNA Vaccine Delivery
Pierrot Harvie
Favorite
Hasabnis, Aakash

University of Minnesota
(M0930-01-02) Predicting Compression Behaviors of Mixtures from Those of Individual Components
Aakash Hasabnis
Favorite
Hasan, Ahasanul

Dhaka University
(W0930-04-27) Novel Blood Pressure Lowering Effects of Statins
Ahasanul Hasan
Favorite
Hasan, Md. Nahid

Duquesne University
(T1130-08-51) Multivariate Analysis of Granule Size Data from Continuous Granulation Screening and Response Surface Studies: A Tool for Process Understanding
Md. Nahid Hasan
Favorite
Hasan, Raquibul

Mercer University
(M1030-04-27) Neflamapimod Inhibits Endothelial Cell Activation and Leukocyte Adhesion by Inhibiting p38 MAPKα and NF-κB Signaling
Raquibul Hasan
Favorite
(W0930-04-27) Novel Blood Pressure Lowering Effects of Statins
Raquibul Hasan
Favorite
Haser, Abbe

Organon & Co., Inc.
(M1130-09-62) A Continuous Future: Demonstrating Proof of Concept for Continuous Post-Drying of Pharmaceutical Spray Dried Intermediates
Abbe Haser
Favorite
(W0930-09-58) Continuous Wet Granulation and Drying: Moving from Technical Feasibility to Commercial Scale
Abbe Haser
Favorite
Hashimoto, Kotaro

Hayashibara Co., Ltd.
(M0930-04-23) Beneficial Effects of Trehalose on Mesenchymal Stem Cell-Derived Exosomes
Kotaro Hashimoto
Favorite
Hassan, Nourhan

Gulf Medical University
(T1330-01-06) Statistical Optimization of Stable Quercetin Nanoparticles for Tumor Targeting
Nourhan Hassan
Favorite
Hattori, Yusuke

Musashino University
(T1030-03-21) Injection-Molded Coamorphous Tablets: Analysis of Intermolecular Interaction and Crystallization Propensity
Yusuke Hattori
Favorite
Hau, Jonathan

Genentech, Inc.
(T1530-11-70) Assessing the Impacts of Drug Loading and Polymer Type on In Vitro Dissolution and Flux Behavior of GDC-A Amorphous Solid Dispersions
Jonathan Hau
Favorite
Havenith, Vanessa

SE Tylose GmbH & Co. KG
(M0930-05-31) Assessment of Stability and Erosion Behavior of ASDs by Using VCM Technique
Vanessa Havenith
Favorite
Haware, Rahul

Natoli Scientific
(T1030-03-20) Material Deformation or Material Hardness or Both: Tool for Predicting Tabletability Performance
Rahul Haware
Favorite
Haware, Rahul

Natoli Engg.
(W0930-11-72) Investigating the Role of Critical Formulation and Process Variables Using Hybrid-Design Approach on the Redispersibility of Spray Dried Co-precipitated Nanoamorphous Micellar Dispersion
Rahul Haware
Favorite
Hawe, Andrea

Coriolis Pharma Reserach GmbH
(M1430-09-56) A Model-Based and Quality-by-Design Compatible Lyophilization Cycle Development Strategy for Biopharmaceuticals
Andrea Hawe
Favorite
Haynes, Kim

Waters Corporation
(T1230-09-58) Systematic Method Development of Deferoxamine Mesylate Forced Degradation Sample
Kim Haynes
Favorite
he, Chunla

University of Florida
(W1030-02-09) Development of an Artificial Intelligence-Based PBPK Model for Nanoparticles in Tumor-Bearing Mice
Chunla he
Favorite
He, Chanson

University of Toronto
(T1130-11-74) Multi-targeted Nanomedicine with Synergistic Doxorubicin and Oligo Hyaluronic Acid for Enhancing Anti-tumor Immunity in the Metastatic Triple-Negative Breast Cancer
Chanson He
Favorite
Hedaya, Mohsen

Kuwait University
(M1430-12-81) Formulation, Optimization, and In Vitro Studies of Atorvastatin Calcium Cocrystals
Mohsen Hedaya
Favorite
Heindel, Ned

Lehigh University
(T1130-11-75) Sonoprecipitation Synthesis of a Multifunctional Prodrug Nanosuspension Using a Quality by Design Approach
Ned Heindel
Favorite
Heinrich, Markus

Friedrich-Alexander-University
(M1430-09-59) Electrophotographic 3D Printing of Pharmaceutical Films
Markus Heinrich
Favorite
Hejazi, Mohammad

Virginia Commonwealth University
(M1330-01-07) Understanding the Relationship Between In Vitro Nasal Spray Characteristics and Intranasal Deposition in the Adult and Pediatric Populations
Mohammad Hejazi
Favorite
Hejmady, Siddhanth

University of Iowa
(M1330-09-57) Unveiling the Impact of Surface Chemistry on Adsorption of a Therapeutic Monoclonal Antibody Using a Quartz Crystal Microbalance
Siddhanth Hejmady
Favorite
(T1430-03-16) Temperature Variations and Impurities Preclude a Reliable Measurement of the Diffusion Interaction Parameter for Monoclonal Antibodies
Siddhanth Hejmady
Favorite
(W0930-12-77) An Insight into the Interrelationship between Colloidal Stability of Protein Therapeutics in Formulation and Their Adsorption to a Solid Surface
Siddhanth Hejmady
Favorite
He, Juan

Biopharma Services Inc.
(M1530-10-69) A Simulation-Based Decision Guide to Evaluate Missing Data in Bioequivalence Studies
Juan He
Favorite
Helal, Nada

Texas A&M Health Sciences Center
(T1030-08-51) Development and Validation of Discriminatory Release Method for Intramammary Drug Products as a Part of In Vitro Quality Metrics
Nada Helal
Favorite
(T1230-10-65) A Survey of Prevalence of Pediatric Dosing for Biologics
Nada Helal
Favorite
(T1530-02-11) In Vivo Characterization and Bioequivalence Study of 3D Printed Tenofovir Disoproxil Fumarate Printlets
Nada Helal
Favorite
Helbig, Constanze

Coriolis Pharma Research GmbH
(M1530-09-57) Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles
Constanze Helbig
Favorite
He, Mei

University of Florida
(M1130-04-24) Collagen Droplet-Based Micro-Bioreactors for High-Throughput Drug Screening
Mei He
Favorite
Hemming, Isabelle

Syntegon
(W1130-09-61) Low Dose Formulations in Continuous Manufacturing of Tablets via Semi-continuous Feeding and Blending
Isabelle Hemming
Favorite
Henderson, Alyssa

Anton Paar USA, Inc.
(T1130-08-49) Excipient Characterization: Solid Density and Surface Area
Alyssa Henderson
Favorite
Henderson, Jeffery

University of Toronto
(T1130-11-74) Multi-targeted Nanomedicine with Synergistic Doxorubicin and Oligo Hyaluronic Acid for Enhancing Anti-tumor Immunity in the Metastatic Triple-Negative Breast Cancer
Jeffery Henderson
Favorite
Hendrix, CBrionne

Texas Southern University
(M1230-10-65) Pharmacokinetic Characterization of a Novel COVID-19 Inhibitor OJT010 in a Rat Model
CBrionne Hendrix
Favorite
Henry, Ana

Certara
(M1030-08-51) Automated In Vitro Population Bioequivalence for Inhaled Products to Meet the FDA Guidance on Budesonide Using Phoenix® WinNonlin®
Ana Henry
Favorite
Henson, Sam

Duquesne University
(M1330-09-59) Development of Iterative Optimization Technology Algorithms with a Small-Scale Feed Frame Simulator: Stagnant vs. Dynamic Pure Component Spectra
Sam Henson
Favorite
(T1130-08-51) Multivariate Analysis of Granule Size Data from Continuous Granulation Screening and Response Surface Studies: A Tool for Process Understanding
Sam Henson
Favorite
Herfort, Inga

Miltenyi Biotec B.V. & CO. KG
(T1030-06-38) Optimizing Flow Cytometric Immune Phenotyping and CAR Persistence Determination to Enable Immune Monitoring of Patients under CAR T Cell Therapy
Inga Herfort
Favorite
Hermans, Eline

Janssen
(M1330-01-04) Characterizing the Drug Gastrointestinal Transfer Process after Disintegration of Solid Dose Units in the Fed State
Eline Hermans
Favorite
Hernandez-Torres, Eduardo

Eli Lilly and Company
(W1030-05-32) Use of DEM to Troubleshoot Aesthetic Defects in Pharmaceutical Tablets
Eduardo Hernandez-Torres
Favorite
Herzig, Susanne

University of Applied Sciences and Arts Northwestern Switzerland
(M1430-03-21) Computational Support to Identify Ternary Solid Dispersions of Hydroxypropyl Cellulose and Small Molecular Additives to Stabilize Challenging Drugs
Susanne Herzig
Favorite
Heshmathi, Niloofar

University of Texas at Austin
(M1230-04-24) A Novel Electrospinning System to Fabricate Bi-axial Nanofibers for Developing a Floating Pharmaceutical Dosage Form
Niloofar Heshmathi
Favorite
Heshuote, Mailisi

Crystal Pharmatech, Inc.
(M1230-09-62) Detecting Low-Level Crystallinity in ASD-Like Samples Using SSNMR Techniques
Mailisi Heshuote
Favorite
Hessberger, Tristan

Chemische Fabrik Budenheim KG
(T1030-04-22) Impact of Solvent Choice in the Spray-Freeze-Drying of Insoluble Excipients
Tristan Hessberger
Favorite
Hessel, Evin

Northeast Ohio Medical University
(M1230-04-22) Effect of Lung Cancer Exosomal Galectin-3 Binding Protein on Bone Metastasis
Evin Hessel
Favorite
Hess, Florian

MilliporeSigma a Business of Merck KGaA
(M0930-12-82) Interaction of Thermal and Rheological Parameters Critical for the Processability of Polyvinyl Alcohol-Based Systems during Hot Melt Extrusion
Florian Hess
Favorite
Hess, Tobias

Chemische Fabrik Budenheim KG
(T1030-04-22) Impact of Solvent Choice in the Spray-Freeze-Drying of Insoluble Excipients
Tobias Hess
Favorite
He, Weiling

Zhejiang Huahai Pharmaceutical Co, Ltd.
(M1430-08-55) Quantitative Determination of Microcrystalline Cellulose in Drug Products by Chemometrics Analysis of Raman Spectroscopy
Weiling He
Favorite
(T1530-08-55) Investigation Study of Color Change in Drug Tablets by Raman Spectroscopy
Weiling He
Favorite
(W1030-08-53) Optimized HPLC Method for the Lacosamide and Its Impurities in the Lacosamide Injection
Weiling He
Favorite
Hewitt, Philip

Merck KGaA
(M1530-10-63) Quantum Electrochemical Spectroscopy (QES): A Novel Approach for Enhanced Detection and Evaluation of Drug-Induced Liver Injury (DILI)
Philip Hewitt
Favorite
Hickey, Anthony

RTI International
(W1030-04-26) Tigecycline Pharmacokinetics after Intrapulmonary Administration in Mice
Anthony Hickey
Favorite
Higashi, Kenjirou

Chiba University
(M1230-01-05) Mechanistic Analysis of Excessive Viscosity Increase of Drug Nanosuspension during Wet Milling
Kenjirou Higashi
Favorite
Higashino, Chie

Pharmaron (Exton) Lab Services LLC
(T1330-04-25) The Impact of Surface Area per Volume Ratio on Drug Transport from Supersaturated Solutions of Ketoconazole
Chie Higashino
Favorite
Higashino, Haruki

Pharmaron (Exton) Lab Services LLC
(T1330-04-25) The Impact of Surface Area per Volume Ratio on Drug Transport from Supersaturated Solutions of Ketoconazole
Haruki Higashino
Favorite
Higashisaka, Kazuma

Osaka University
(T1130-04-22) The Effect and Distribution of Amorphous Nanosilica Particle in the Brain and Microglial Cells
Kazuma Higashisaka
Favorite
(W1130-04-22) Valproic Acid Elevates HIF-1α-mediated CGB Expression and Suppresses Glucose Uptake in BeWo Cells
Kazuma Higashisaka
Favorite
Higgins, Rehan

Precision NanoSystems, Inc.
(M1530-12-83) Effect of LNP Components on mRNA-Mediated Protein Expression of Lipid Nanoparticles in Different Organs
Rehan Higgins
Favorite
Higuchi, Masaharu

Asahi Kasei Corp.
(M1130-08-51) Comparative Study of Suitability for Wet Continuous Production Process Using MCC with Different Characteristics
Masaharu Higuchi
Favorite
Hildebrand, Staffan

University of Bonn
(M1130-05-32) Targeted Transport of Active Pharmaceutical Ingredients into Adipose Tissue and Liver
Staffan Hildebrand
Favorite
Hindle, Michael

Virginia Commonwealth University
(M1330-01-07) Understanding the Relationship Between In Vitro Nasal Spray Characteristics and Intranasal Deposition in the Adult and Pediatric Populations
Michael Hindle
Favorite
(W1130-02-10) Excipient Enhanced Growth (EEG) Synthetic Lung Surfactant Powder Formulation for Treating Neonatal Respiratory Distress Syndrome (NRDS)
Michael Hindle
Favorite
Hinnershitz, Tina

Pfizer Inc.
(W1230-10-68) A Phase 1, Open-Label, Single-Period, Nonrandomized Study of the Pharmacokinetics, Excretion, Mass Balance and Metabolism of Oral [¹⁴C] PF-07265803 (ARRY-371797) in Healthy Male Adults
Tina Hinnershitz
Favorite
Hirowatari, Kazunari

SNBL
(M1030-06-39) Robust Quantification Method Development for Antisense Oligonucleotide by LC-MS/MS
Kazunari Hirowatari
Favorite
(T1030-06-39) Optimal Mobile Phase and Antisense Oligonucleotide Modifications for the Internal Standard in Bioanalysis of Therapeutic Oligonucleotides by Ion-Pair LC-MS/MS
Kazunari Hirowatari
Favorite
Hladek, Filip

University of Chemistry and Technology Prague
(M1530-01-03) Drug Nanocrystals Enable Rapid Formulation Transfer from Liquid-Phase Pre-clinical Testing to First-in-Human Solid Dosage Forms
Filip Hladek
Favorite
Hoag, Stephen

University of Maryland
(M1130-11-73) Hydroxypropyl-β-cyclodextrin (HPBCD) in Insoluble Drug-Loaded Nanoparticles Dissolution Studying: A New Approach to Overcoming Sink Limitations
Stephen Hoag
Favorite
(T1030-03-15) Expanding the Space of Hydroxyl-Rich Lyoprotectants through High-Throughput Screening to Support the Lyophilization of Yeast-Based Therapeutics
Stephen Hoag
Favorite
(T1030-11-76) The Physicochemical Properties and Morphological Changes of PLGA-PEG Nanoparticles During Long-Term In Vitro Release
Stephen Hoag
Favorite
(T1430-02-08) Bioadhesive and Sustained Release Epinephrine-Loaded Sodium Alginate Hydrogel Accelerates Hemostasis to Manage Gastrointestinal Bleeding
Stephen Hoag
Favorite
(W1130-02-11) Interaction between Different Types of Excipients and Protein
Stephen Hoag
Favorite
Hoashi, Yasutaka

Takeda Pharmaceutical Company Limited
(W1030-12-77) Application of Machine Learning to the Development of Lipid Nanoparticle
Yasutaka Hoashi
Favorite
Hochhaus, Guenther

University of Florida
(T1230-02-10) Evaluating the Dissolution of Commercially Available Metered Dose Inhaler (MDI) Drug Products from Realistic In Vitro Experiments
Guenther Hochhaus
Favorite
Hoehne, Steven

Worldwide Clinical Trails
(M1330-06-36) Determination of Microdystrophin (h-µD5) via Signature Peptide Analysis in Muscle Tissue by LC-MS/MS
Steven Hoehne
Favorite
Hofmann, Nicole

EMD Serono
(T1230-12-79) P188 – Polymeric Carrier for Solid Dispersion Enabling Formulations of PROTACs
Nicole Hofmann
Favorite
Ho, Gloria

BASF Corporation
(T1430-01-05) Influence of Kollicream^® OD on Ibuprofen Skin Permeation and Retention
Gloria Ho
Favorite
Hohenleutner, Andreas

Solvias
(T1030-08-54) Addressing Particulate Matter in Protein Therapeutics
Andreas Hohenleutner
Favorite
Ho, HsinPin

Bristol Myers Squibb Company
(M1130-06-37) Bioanalytical Assessments of a Novel Approach to Overcome Microsampling Challenges in Rodent Studies
HsinPin Ho
Favorite
Holkunde, Aditi

University of Mississippi
(M0930-01-07) Three-Dimensional Extrusion Based Bioprinting of Metronidazole Immediate Release Tablets; Impact of Processing Parameters on In Vitro Evaluation
Aditi Holkunde
Favorite
Holland, Brandon

Tergus Pharma, LLC
(M0930-11-76) The Impact of Relative Humidity on In Vitro Permeation Test Method Performance Indicators, J_max, T_max and Amount Permeated for Molecule, TER-003
Brandon Holland
Favorite
(T1030-11-73) Industry Understanding for Overcoming Challenges to Demonstrate IVPT Sensitivity by Dose Amount and Dose Duration Modulation as per FDA Draft Guidance for Topical Drug Products
Brandon Holland
Favorite
(T1530-11-72) Evaluation of Supported-Liquid Extraction Technique and Matrix Effect in LCMS-MS Method Development of a Model Hydrophobic Drug
Brandon Holland
Favorite
Holley, Claire

Nanotechnology Characterization Laboratory
(M1130-06-38) Innate Immune Response Modulating Impurities Assay for Assessing Synthetic Semaglutide and Liraglutide
Claire Holley
Favorite
Holm, René

University of Southern Denmark
(M1030-01-03) A Case Study on the Applicability of the Refined Developability Classification System to Identify Compounds Suitable for Biowaivers: Voriconazole
René Holm
Favorite
(M1530-03-20) Digestion Is a Critical Element for Absorption of Cinnarizine from Supersaturated Lipid-Based Type I Formulations
René Holm
Favorite
(T1130-05-34) Digestion Is an Important Element for Absorption of Cinnarizine from Supersaturated Lipid-Based Type II Formulations
René Holm
Favorite
Holstein, Sarah

University of Nebraska Medical Center
(W1030-04-22) Combination Therapy of Geranylgeranyl Diphosphate Synthase Inhibitor and Fatty Acid Synthase Inhibitor in Multiple Myeloma
Sarah Holstein
Favorite
(W1130-04-27) The Effect of MO-OH-Nap Tropolone on Osteosarcoma Cellular Metabolism
Sarah Holstein
Favorite
Honda, Mamoru

Qualicaps Co., Ltd.
(M0930-04-25) A Compatibility Test of Two-Piece Hard Capsules and Liquid/Semi-solid Excipients - Part 2
Mamoru Honda
Favorite
Hong, Ji Su

CCNets Inc.
(T1530-09-59) Development of the Quantitative Prediction Model by Applying Chemometric and Artificial Intelligence in the Near-Infrared Spectrum as Pharmaceutical Process Analytical Technology
Ji Su Hong
Favorite
Hong, Paula

Waters Corporation
(M1030-06-40) Optimizing Detector Settings for Method Scaling-Meeting System Suitability Criteria
Paula Hong
Favorite
Hong, Seungpyo

University of Wisconsin Madison
(W0930-02-13) Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery
Seungpyo Hong
Favorite
(W1230-01-06) Fibronectin-Targeted Dendron Micelles to Effectively Deliver BRD4-Inhibitors for Inflammation Reduction in an Idiopathic Pulmonary Fibrosis Model
Seungpyo Hong
Favorite
Hong, Zhong

Chongqing Denali Medpharma Ltd
(M1030-06-37) Strategies and Case Studies to Develop Ultra-sensitive LC-MS/MS Assays for Quantification of Inhalation Drugs in Human Plasma
Zhong Hong
Favorite
Hopkins, Caroline

University of Wisconsin Madison
(W1230-01-06) Fibronectin-Targeted Dendron Micelles to Effectively Deliver BRD4-Inhibitors for Inflammation Reduction in an Idiopathic Pulmonary Fibrosis Model
Caroline Hopkins
Favorite
Horton, Andrew

International Flavors and Fragrances Inc.
(W0930-11-73) Oral Tablets Containing a Model Protein API – Impacts of Excipient Selection, API Loading, Unit Operation, and Manufacturing Process Parameters on Tablet Properties, Performance, and Stability
Andrew Horton
Favorite
Hoshina, Wataru

Takeda Pharmaceutical Company Limited
(W1030-12-77) Application of Machine Learning to the Development of Lipid Nanoparticle
Wataru Hoshina
Favorite
Hoshino, Takafumi

Shin-Etsu Chemical Co., Ltd.
(T1530-12-79) Dissolution Technology Using HPMCAS Solid Dispersion Targeting the Upper Small Intestine
Takafumi Hoshino
Favorite
Ho, Tricia

Duke University
(M1230-05-33) Concurrent Regulation of OATP1B1 Transport Function by Protein Phosphorylation and Acetylation: Novel Mechanism Underlying Reduced Function of OATP1B1 c.521T >C Single Nucleotide Polymorphism
Tricia Ho
Favorite
(T1130-05-32) Global Identification of OATP1B1-Associated Proteins and Implications of Calcineurin Inhibition in Time-Dependent OATP1B1 Inhibition
Tricia Ho
Favorite
(T1230-05-32) Regulation of OATP1B3 Transport Function via Protein Acetylation
Tricia Ho
Favorite
Hou, Hao Helen

Genentech, Inc.
(T1430-11-70) Assessing the Impact of Dry Particle Coating with Nano-Silica on Compaction Properties of Cohesive Active Pharmaceutical Ingredients
Hao Helen Hou
Favorite
(T1530-11-70) Assessing the Impacts of Drug Loading and Polymer Type on In Vitro Dissolution and Flux Behavior of GDC-A Amorphous Solid Dispersions
Hao Helen Hou
Favorite
Hou, Helen

Genentech, Inc.
(W1030-01-01) Investigating the Relationship between Material Attributes of API and the Extent of Powder Property Enhancement via Dry Particle Coating with Nano-Silica
Helen Hou
Favorite
Hou, Jingguo

Worldwide Clinical Trails
(M1330-06-36) Determination of Microdystrophin (h-µD5) via Signature Peptide Analysis in Muscle Tissue by LC-MS/MS
Jingguo Hou
Favorite
Hou, Shuyu

Medpace Bioanalytical Laboratories
(M1030-10-67) Determination of the Concentration of the Drug MG1113 in Human Sodium Citrate Plasma Using a Sandwich Electro Chemiluminescent Immunoassay (ECLIA)
Shuyu Hou
Favorite
Howe, Connor

Virginia Commonwealth University
(W1130-02-10) Excipient Enhanced Growth (EEG) Synthetic Lung Surfactant Powder Formulation for Treating Neonatal Respiratory Distress Syndrome (NRDS)
Connor Howe
Favorite
Howlader, Ahsanul

Colorcon, Inc.
(T1230-11-72) Evaluation of Developmental TiO2 Free High Productivity and High Opacity Coating System at Different Scales
Ahsanul Howlader
Favorite
Howlader, Md Sariful Islam

Texas Tech University Health Science Center
(M1130-04-22) Mitochondrial Activity and Function are Modulated by KLF2 in Rheumatoid Arthritis
Md Sariful Islam Howlader
Favorite
Hua, Fei

Applied BioMath
(M1130-10-65) A Next Generation Mathematical Model for the In Vitro to Clinical Translation of T-Cell Engagers
Fei Hua
Favorite
Huang, Chunghui

Auburn University
(M1530-11-74) Micellar Codelivery of DQ, a Disulfiram Based Prodrug with In Situ Copper Ions Chelation for Cancer Therapy
Chunghui Huang
Favorite
(W1030-04-24) Diethyldithiocarbamate Copper Nanoparticle Overcomes Resistance in Cancer Therapy without Inhibiting P-glycoprotein
Chunghui Huang
Favorite
Huang, Jing

Zhejiang Huahai Pharmaceutical Co, Ltd.
(W1030-08-53) Optimized HPLC Method for the Lacosamide and Its Impurities in the Lacosamide Injection
Jing Huang
Favorite
Huang, Juyang

Texas Tech University Health Sciences Center
(T1330-04-27) Effect of Propofol on Lipid Membrane Fluidity and Blood-Brain Barrier Permeability
Juyang Huang
Favorite
Huang, Michael

International Flavors and Fragrances Inc.
(T1130-11-70) Application of Colloidal MCC and Xanthan in Challenging Suspension Formulation
Michael Huang
Favorite
(T1230-02-08) Application of Ac-Di-Sol® SD-711 in Orally Disintegrating Tables (ODTs): Performance Comparison of Croscarmellose Sodium and Crospovidone
Michael Huang
Favorite
Huang, Pin-Syuan

University of Minnesota
(T1330-12-79) Sweet Levofloxacin Acesulfame Crystals with Improved Compaction Property and Solvates Interconversion
Pin-Syuan Huang
Favorite
Huang, Ying

Jinan University
(M1430-11-75) Rizatriptan Nasal Spray with Effective Olfactory Deposition for Improving Migraine Treatment
Ying Huang
Favorite
(W1230-11-71) Dissolving Microneedle Patches for Enhanced Melanoma Ferroptosis Therapy Based on a Lipophagy-Fueled Strategy
Ying Huang
Favorite
Huang, Yue

AstraZeneca
(M1430-06-39) A Comprehensive Array of Bioanalytical Assays to Assess the Pharmacokinetic Properties of Antibody-Drug Conjugates In Vivo and In Vitro
Yue Huang
Favorite
Huang, Zhengwei

Jinan University
(W1230-11-71) Dissolving Microneedle Patches for Enhanced Melanoma Ferroptosis Therapy Based on a Lipophagy-Fueled Strategy
Zhengwei Huang
Favorite
Hu, Chunyan

WuXi AppTec (Suzhou)
(W1130-06-37) Validation of an In Vitro Cell-Based Assay for the Detection of Neutralizing Antibodies against Adeno-Associated Virus 9 in Cynomolgus Monkey
Chunyan Hu
Favorite
Hudson, Loyd

Eli Lilly and Company
(T0930-10-65) Human Renal Clearance Prediction Using Monkey
Loyd Hudson
Favorite
Huebner, Brian

Ashland Specialty Ingredients
(T1130-01-03) Evaluating the Versatility of the New High Molecular Weight HPC in Dual Active Diabetic Controlled Release Dosages
Brian Huebner
Favorite
(T1330-01-04) Demonstrating the Utility of a New High Molecular Weight HPC to Make Smaller Modified Release Tablets
Brian Huebner
Favorite
Huffman, Dawn

Catalent Pharma Solutions
(M1130-12-77) Stabilization and Formulation Development of Lipid Nanoparticles (LNPs) for Nucleic Acid-Based Therapeutics
Dawn Huffman
Favorite
Hu, Gangqing

West Virginia University
(M0930-04-27) High-Resolution Sequencing Comparison of the DNA Methylome and Hydroxymethylome in Leukemia and Normal Blood Cells
Gangqing Hu
Favorite
Hui, Jeremy

Probius Inc
(M1530-10-63) Quantum Electrochemical Spectroscopy (QES): A Novel Approach for Enhanced Detection and Evaluation of Drug-Induced Liver Injury (DILI)
Jeremy Hui
Favorite
(T1430-06-37) Quantum Electrochemical Spectroscopy (QES): A Novel AI-Driven Spectroscopic Approach to Simplify Bioanalytical Development in the Pharmaceutical and Biotech Industries
Jeremy Hui
Favorite
Hui, Yu-Hua

Eli Lilly and Company
(T0930-10-65) Human Renal Clearance Prediction Using Monkey
Yu-Hua Hui
Favorite
Hu, Meng

US Food and Drug Administration
(M1230-05-30) Application of Quantitative Models to Systematically Evaluate Factors Impacting Swallowability of Tablets
Meng Hu
Favorite
(M1430-10-65) Comparing a t-Distribution Based Bayesian Approach with the Two One-Sided t-Test (TOST) for Bioequivalence Studies in Real-World Datasets
Meng Hu
Favorite
Hummler, Henriette

F. Hoffman-La Roche , Ltd.
(T0930-01-05) Acceptable Solid Oral Dosage Forms for Older Adults as Prerequisite for Medication Adherence – The Current Situation
Henriette Hummler
Favorite
Hussain, Muhammad

University of Maryland Eastern Shore
(M1130-01-06) Formulation and In Vitro Anticancer Activity of Folate Receptor Targeted PLGA Nanoparticles Loaded with Apigenin
Muhammad Hussain
Favorite
(T1530-03-19) Utilization of Polymeric Micelles to Enhance Anticancer Activity through Combined Therapy with Luteolin and Doxorubicin
Muhammad Hussain
Favorite
Hutchison, Sandy

SentrySciences
(M1530-09-57) Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles
Sandy Hutchison
Favorite
Hu, Yang

Uppsala University
(W0930-05-30) Comparison of Paclitaxel Distribution across CNS and PNS Barriers after Administration of Cremophor EL/Ethanol Solubilized, Albumin-Bound and Micellar Paclitaxel
Yang Hu
Favorite
Huybrechts, Tom

Janssen
(M1030-08-55) Correlating Tablet Performance Differences to Tablet Microstructure Via MFV-SEM and XRM Imaging Coupled with AI Image Analytics
Tom Huybrechts
Favorite
Hwang, Da-Eun

National Institute of Food and Drug Safety Evaluation
(T1130-05-31) Development and Validation of Quantitative Analysis Method for Testosterone Derivatives in Natural musk(Moschus) Using GC-MS
Da-Eun Hwang
Favorite
Hwang, Jinhee

National Institute of Food and Drug Safety Evaluation
(T1130-05-31) Development and Validation of Quantitative Analysis Method for Testosterone Derivatives in Natural musk(Moschus) Using GC-MS
Jinhee Hwang
Favorite
Hwang, Sung-joo

Yonsei University
(M1030-03-17) Enhance Transport of Adenosine Integrated in Lipid Nanoparticles Crossing Reconstructed Human Epidermis
Sung-joo Hwang
Favorite
(M1430-03-17) Optimizing Microfluidic Process Parameters and Lipid-Cholesterol Composition for Lysozyme-Loaded Liposome Preparation
Sung-joo Hwang
Favorite
(W1130-03-18) Formulation and Development of Rivastigmine tartrate Sustained-Release Tablets
Sung-joo Hwang
Favorite
(W1130-03-19) Optimization of Process Parameters for Apixaban Long-Acting Parental PLGA Microspheres
Sung-joo Hwang
Favorite
Hwang, Sung-Yong

US Food and Drug Administration
(W0930-03-20) In Vitro Evaluation of Two Morphine Sulfate Extended-Release Products Sprinkled on Soft Foods
Sung-Yong Hwang
Favorite
Hwang, Yu-Jung

Seoul National University
(T0930-12-78) Preparation and Evaluation of Dexamethasone Phosphate-Encapsulated Liposomal Gel Formulation for Intratympanic Delivery
Yu-Jung Hwang
Favorite
Hyde, Ricia

University of Nebraska Medical Center
(M1030-02-08) A Novel Liposomal Delivery for MicroRNA-497 and Venetoclax in Acute Myeloid Leukemia
Ricia Hyde
Favorite
Hynes, Scott

Reata Pharmaceuticals
(T1130-10-65) A Phase 1, Randomized, Open-Label, Single-Dose, Crossover, Relative Bioavailability Study of Omaveloxolone Intact Capsules versus Capsule Contents Sprinkled on Applesauce in Healthy Adult Subjects
Scott Hynes
Favorite
Hyun, Sang Min

Dong-A ST
(W0930-11-75) Discovery and Development of Memantine Transdermal Patch
Sang Min Hyun
Favorite
(W1130-11-74) Pre-clinical and Clinical Evaluation of a Weekly Donepezil Transdermal Patch
Sang Min Hyun
Favorite